About Us
SGS CDMO Solutions, based in Deeside, partners with biopharma innovators to deliver seamless, end-to-end development and manufacturing services that accelerate products from concept to clinic and beyond.
SGS CDMO Solutions provides integrated formulation, analytical, and GMP manufacturing services to support the efficient development and delivery of new therapies.
About Us
2002
QuayPharma was founded in 2002 as a specialist formulation and drug-development CDMO.
2010
Moved to our current site based in Deeside.
2016
GMP licence granted.
108
Employees
60+
Scientists
8
Commercial Products
2018
1st UK site to receive LBP licence.
2021
SGS acquire QuayPharma.
15
Nations Onsite
14+
PHD Students
28
Current Projects
28 Parkway
Deeside Industrial Park
Flintshire, CH5 2NS
LOCATION
Jamie Farrar
Head of Drug Development
Paul Broomhead
Head of Site
Head of Commercial Operations
Russ Pursell
Meet the team
Meet the team committed to delivering exceptional development and manufacturing services.
Compliance Audits
David Leslie
